Mkts

Apogee Therapeutics, Inc.

NASDAQ: APGE
$0.00-0.01 (-0.01%)
As of Dec 31, 7:00 PM ET

Key statistics

52-week range
56.52135.09
Today
Open0.00
Previous close0.00
Volume—
Valuation
Market cap10.22B
P/E ratio—
EPS (TTM)-4.34
Income & risk
Dividend / yield—
Beta1.75
Avg volume2.21M
Discussion

APGE News

Stories mentioning APGE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development60,81958,44454,17855,70346,38760,22945,71433,206
Sales General & Admin
Total Operating Expenses82,77278,05671,27873,16563,09675,88158,68644,122
Operating Income (Loss)(82,772)(78,056)(71,278)(73,165)(63,096)(75,881)(58,686)(44,122)
Interest Income8,7408,7316,3187,1417,8408,6819,66810,306
Interest Expense
Other Expense8,7408,7316,3187,1417,8408,6819,66810,306
Pretax Income(74,032)(69,325)(64,960)(66,024)(55,256)(67,200)(49,018)(33,816)
Tax Provision79.0062.0061.0072.0083.0018.000.000.00
Net Income (Loss)(74,111)(69,387)(65,021)(66,096)(55,339)(67,218)(49,018)(33,816)
Earnings Per Share (Basic)(1.06)(1.14)(1.11)(1.13)(0.95)(1.22)(0.86)(0.60)
Earnings Per Share (Diluted)(1.06)(1.14)(1.11)(1.13)(0.95)(1.22)(0.86)(0.60)
Weighted Average Shares Outstanding (Basic)69,66860,69158,77458,42858,19555,19456,79656,515
Weighted Average Shares Outstanding (Diluted)69,66860,69158,77458,42858,19555,19456,79656,515

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About APGE

Apogee Therapeutics, Inc. (NASDAQ: APGE) is a stock listed on the Nasdaq Stock Market under the ticker symbol APGE. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET), down 0.0% on the day. That gives Apogee Therapeutics a market capitalisation of $10.2B.

Over the past 52 weeks APGE has traded between $56.52 and $135.09.

For the quarter ended Mar 31, 2026 it reported a net loss of $74.1M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$74.1M
Dec 31, 2025—-$69.4M
Sep 30, 2025—-$65.0M
Jun 30, 2025—-$66.1M

From Apogee Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…